BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 17663607)

  • 21. Positive extreme responding after cognitive therapy for depression: Correlates and potential mechanisms.
    Forand NR; Strunk DR; DeRubeis RJ
    Behav Res Ther; 2016 Aug; 83():11-8. PubMed ID: 27236074
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Relapse and recurrence in pediatric depression.
    Kennard BD; Emslie GJ; Mayes TL; Hughes JL
    Child Adolesc Psychiatr Clin N Am; 2006 Oct; 15(4):1057-79, xi. PubMed ID: 16952775
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Experimental evidence for a motivational origin of cognitive impairment in major depression.
    Scheurich A; Fellgiebel A; Schermuly I; Bauer S; Wölfges R; Müller MJ
    Psychol Med; 2008 Feb; 38(2):237-46. PubMed ID: 18005498
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Adolescent depression: evaluating pediatric residents' knowledge, confidence, and interpersonal skills using standardized patients.
    Lewy C; Sells CW; Gilhooly J; McKelvey R
    Acad Psychiatry; 2009; 33(5):389-93. PubMed ID: 19828852
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Risk factors for relapse after remission with repetitive transcranial magnetic stimulation for the treatment of depression.
    Cohen RB; Boggio PS; Fregni F
    Depress Anxiety; 2009; 26(7):682-8. PubMed ID: 19170101
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Taxonomy of high-risk situations for alcohol relapse: evolution and development of a cognitive-behavioral model.
    Marlatt GA
    Addiction; 1996 Dec; 91 Suppl():S37-49. PubMed ID: 8997780
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cognitive-behavior therapy for depressed cancer patients in a medical care setting.
    Hopko DR; Bell JL; Armento M; Robertson S; Mullane C; Wolf N; Lejuez CW
    Behav Ther; 2008 Jun; 39(2):126-36. PubMed ID: 18502246
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Development of an outcome prediction measure for alcoholism therapy by multimodal monitoring of treatment processes.
    Krampe H; Stawicki S; Ribbe K; Wagner T; Bartels C; Kroener-Herwig B; Ehrenreich H
    J Psychiatr Res; 2008 Nov; 43(1):30-47. PubMed ID: 18342335
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mood induced cognitive and emotional reactivity, life stress, and the prediction of depressive relapse.
    Lethbridge R; Allen NB
    Behav Res Ther; 2008 Oct; 46(10):1142-50. PubMed ID: 18707676
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Relapse rate within 6 months after successful ECT: a naturalistic prospective peer- and self-assessment analysis].
    Rehor G; Conca A; Schlotter W; Vonthein R; Bork S; Bode R; Hüll M; Plewnia C; Di Pauli J; Prapotnik M; Peters O; Peters J; Eschweiler GW
    Neuropsychiatr; 2009; 23(3):157-63. PubMed ID: 19703381
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Single-participant assessment of treatment mediators: strategy description and examples from a behavioral activation intervention for depressed adolescents.
    Gaynor ST; Harris A
    Behav Modif; 2008 May; 32(3):372-402. PubMed ID: 18391053
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long-term weekly continuation electroconvulsive therapy: a case series.
    Zisselman MH; Rosenquist PB; Curlik SM
    J ECT; 2007 Dec; 23(4):274-7. PubMed ID: 18090702
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Predictors of relapse in a study of duloxetine treatment in patients with major depressive disorder.
    Fava M; Wiltse C; Walker D; Brecht S; Chen A; Perahia D
    J Affect Disord; 2009 Mar; 113(3):263-71. PubMed ID: 18625521
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Adding cognitive therapy to dietetic treatment is associated with less relapse in obesity.
    Werrij MQ; Jansen A; Mulkens S; Elgersma HJ; Ament AJ; Hospers HJ
    J Psychosom Res; 2009 Oct; 67(4):315-24. PubMed ID: 19773024
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mindfulness-based cognitive therapy: evaluating current evidence and informing future research.
    Coelho HF; Canter PH; Ernst E
    J Consult Clin Psychol; 2007 Dec; 75(6):1000-5. PubMed ID: 18085916
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cognitive and behavioral changes related to symptom improvement among patients with a mood disorder receiving intensive cognitive-behavioral therapy.
    Christopher MS; Jacob KL; Neuhaus EC; Neary TJ; Fiola LA
    J Psychiatr Pract; 2009 Mar; 15(2):95-102. PubMed ID: 19339843
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Adherence to continuation and maintenance antidepressant use in recurrent depression.
    ten Doesschate MC; Bockting CL; Schene AH
    J Affect Disord; 2009 May; 115(1-2):167-70. PubMed ID: 18760488
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Maintenance of gains following experiential therapies for depression.
    Ellison JA; Greenberg LS; Goldman RN; Angus L
    J Consult Clin Psychol; 2009 Feb; 77(1):103-12. PubMed ID: 19170457
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Recurrence of major depressive disorder is predicted by inhibited startle magnitude while recovered.
    O'Brien-Simpson L; Di Parsia P; Simmons JG; Allen NB
    J Affect Disord; 2009 Jan; 112(1-3):243-9. PubMed ID: 18495249
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prevalence and psychosocial factors of anxiety and depression in breast cancer patients.
    Lueboonthavatchai P
    J Med Assoc Thai; 2007 Oct; 90(10):2164-74. PubMed ID: 18041438
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.